Jasper Therapeutics, Inc. (JSPR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 35.08M |
| Enterprise Value | 7.62M |
| P/E Ratio | -0.13 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.55 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.63 |
| Return On Equity | -5.23 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.06M |
| EBITDA | -74.75M |
| Net Income | -75.8M |
| Diluted EPS | -3.95 |
| Total Cash | 14.14M |
| Total Cash/Share | 0.74 |
| Total Debt | 757,000 |
| Total Debt/Equity | 0.22 |
| Current Ratio | 2.26 |
| Book Value Per Share | 0.18 |
| 52-Week Change | -91.17 |
| 52-Week High | 7.19 |
| 52-Week Low | 0.42 |
| Moving Average 50 Days | 0.8 |
| Moving Average 200 Days | 1.53 |
| Average Volume | 513,293 |
| Shares Outstanding | 16.25M |
| % Held by Institutions | 82.5 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | January 04, 2024 |